Transdermal estradiol + oral progesterone versus oral conjugated equine estrogens + medroxyprogesterone acetate on normal breast cell proliferation

Phase 4, randomised trial of estradiol, progesterone and conjugated equine estrogen + medroxyprogesterone acetate in menopause (2 arms), sponsored by Karolinska University Hospital. Primary endpoints: Breast cell turnover and Apoptosis in normal breast tissue. Started Aug 2005; status: active.